OSI Pharmaceuticals (OSIP) - formerly Oncogene Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (125)	11/9/2000 6:14:09 AM
From: Micawber	Read Replies (1) of 447

Thursday November 9, 6:00 am Eastern Time Press Release SOURCE: OSI Pharmaceuticals, Inc. OSI Pharmaceuticals Updates Phase II Data for the Company's Lead Anti-Cancer Compound, OSI-774 - Data for Patients with Non-Small Cell Lung and Head and Neck Cancers Presented at the European Organization for the Research and Treatment of Cancer (EORTC) Symposium in Amsterdam - biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next